XOMA - XOMA Corp
IEX Last Trade
28.86
0 0%
Share volume: 0
Last Updated: Fri 20 Dec 2024 09:01:15 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.46%
PREVIOUS CLOSE
CHG
CHG%
$28.86
-3.36
0.13%
Fundamental analysis
11%
Profitability
0%
Dept financing
9%
Liquidity
75%
Performance
5%
Performance
5 Days
-0.04%
1 Month
-10.17%
3 Months
0.15%
6 Months
5.03%
1 Year
47.45%
2 Year
60.25%
Key data
Stock price
$28.86
DAY RANGE
$25.50 - $28.86
52 WEEK RANGE
$18.85 - $35.00
52 WEEK CHANGE
$47.45
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/12/2024
Company detail
CEO: James R. Neal, EMBA
Region: US
Website: xoma.com
Employees: 10
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: xoma.com
Employees: 10
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets with commercial sales potential.
Recent news